{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:05:57Z","timestamp":1789815957237,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Juvenile-onset Inflammatory Rheumatisms (JIR) are rare systemic inflammatory diseases that begin in childhood or adolescence. Numerous recommendations have been developed to support physicians, but implementation may vary in real-life. The JIR-Clinical Practice Strategies (CliPS) project investigates clinical practices for JIR diseases. This article describes the rationale of the JIR-CliPS project to serve as methodological foundation for future publications on disease-specific findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The JIR-CLiPS network was launched in 2020 to collect CliPS in real-life on five medical conditions: lupus nephritis, vasculitis (including IgA vasculitis and Kawasaki disease), use of biologicals for hereditary autoinflammatory diseases, periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAFA) \/ systemic undefined recurrent fevers (SURF) syndrome, and Still\u2019s disease. Specific questionnaires were developed, covering physician demographics, disease-specific approaches, and local healthcare constraints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From June 2022 to April 2024, 534 physicians from 66 countries across six continents participated, completing in 1,193 questionnaires. Respondents were primarily pediatricians and rheumatology specialists, working both at universities and in local hospitals; although most participants reported at least 10 years\u2019 experience, younger doctors also took part. Participants from only a few countries shared the development of local or national JIR-specific recommendations, with variable awareness and adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The JIR-CliPS network has achieved broad international physician participation. Thanks to the knowledge gathered, a library with CliPS adapted to various local and country-specific constraints is currently under development, bridging the gap between published recommendations and achievable everyday practice. This robust methodology ensures a comprehensive and globally representative dataset for future disease-specific publications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04276-8","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:29:44Z","timestamp":1775723384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Juvenile Inflammatory Rheumatism Real-Life Clinical Practice Strategies (JIR-CliPS) network: methodology and the development process"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8953-329X","authenticated-orcid":false,"given":"Helmut","family":"Wittkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Carlomagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Costa Duarte Lanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzifa","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiva","family":"Gorczyca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann","family":"Kallinich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezgin","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausra","family":"Snipaitiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Theodoropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Toplak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Hentgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the JIR-CliPS network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"4276_CR1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/MEG.0000000000000634","volume":"28","author":"PMLA van den Bemt","year":"2016","unstructured":"van den Bemt PMLA, Chaaouit N, van Lieshout EMM, et al. Noncompliance with guidelines on proton pump inhibitor prescription as gastroprotection in hospitalized surgical patients who are prescribed NSAIDs. Eur J Gastroenterol Hepatol. 2016;28:857\u201362. https:\/\/doi.org\/10.1097\/MEG.0000000000000634.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4276_CR2","doi-asserted-by":"publisher","first-page":"e0128237","DOI":"10.1371\/journal.pone.0128237","volume":"10","author":"AC Drenth-van Maanen","year":"2015","unstructured":"Drenth-van Maanen AC, van Marum RJ, Jansen PAF, et al. Adherence with dosing guideline in patients with impaired renal function at hospital discharge. PLoS ONE. 2015;10:e0128237. https:\/\/doi.org\/10.1371\/journal.pone.0128237.","journal-title":"PLoS ONE"},{"key":"4276_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40487-023-00255-2","volume":"12","author":"H Chen","year":"2024","unstructured":"Chen H, Wen Y, Zeng Y, et al. Patient versus physician perspective in the management of chronic myeloid leukemia during treatment with tyrosine kinase inhibitors. Oncol Ther. 2024;12:131\u201345. https:\/\/doi.org\/10.1007\/s40487-023-00255-2.","journal-title":"Oncol Ther"},{"key":"4276_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13023-023-02667-9","volume":"18","author":"M Gittus","year":"2023","unstructured":"Gittus M, Chong J, Sutton A, et al. Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review. Orphanet J Rare Dis. 2023;18:140. https:\/\/doi.org\/10.1186\/s13023-023-02667-9.","journal-title":"Orphanet J Rare Dis"},{"key":"4276_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13023-023-02812-4","volume":"18","author":"Y Vyzhga","year":"2023","unstructured":"Vyzhga Y, Hentgen V, Caorsi R, et al. Breaking down the fences among registries on autoinflammatory diseases: the E-Merge project. Orphanet J Rare Dis. 2023;18:191. https:\/\/doi.org\/10.1186\/s13023-023-02812-4.","journal-title":"Orphanet J Rare Dis"},{"key":"4276_CR6","doi-asserted-by":"publisher","first-page":"744780","DOI":"10.3389\/fimmu.2021.744780","volume":"12","author":"C Vinit","year":"2021","unstructured":"Vinit C, Georgin-Lavialle S, Theodoropoulou A, et al. Real-Life indications of Interleukin-1 blocking agents in hereditary recurrent fevers: data from the jircohort and a literature review. Front Immunol. 2021;12:744780. https:\/\/doi.org\/10.3389\/fimmu.2021.744780.","journal-title":"Front Immunol"},{"key":"4276_CR7","doi-asserted-by":"publisher","first-page":"108697","DOI":"10.1016\/j.clim.2021.108697","volume":"226","author":"I Luu","year":"2021","unstructured":"Luu I, Nation J, Page N, et al. Undifferentiated recurrent fevers in pediatrics are clinically distinct from PFAPA syndrome but retain an IL-1 signature. Clin Immunol. 2021;226:108697. https:\/\/doi.org\/10.1016\/j.clim.2021.108697.","journal-title":"Clin Immunol"},{"key":"4276_CR8","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3390\/jcm10091963","volume":"10","author":"R Papa","year":"2021","unstructured":"Papa R, Penco F, Volpi S, et al. Syndrome of undifferentiated recurrent fever (SURF): an emerging group of autoinflammatory recurrent fevers. J Clin Med. 2021;10:1963. https:\/\/doi.org\/10.3390\/jcm10091963.","journal-title":"J Clin Med"},{"key":"4276_CR9","unstructured":"https:\/\/www.aeped.es\/sites\/default\/files\/documentos\/33_fmf.pdf. Accessed 22 July 2024."},{"key":"4276_CR10","unstructured":"https:\/\/www.aeped.es\/sites\/default\/files\/documentos\/19_kawasaki.pdf. Accessed 22 July 2024."},{"key":"4276_CR11","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term management of Kawasaki disease: A scientific statement for health professionals from the American heart association. Circulation. 2017;135:e927\u201399. https:\/\/doi.org\/10.1161\/CIR.0000000000000484.","journal-title":"Circulation"},{"key":"4276_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.rbre.2015.08.019","volume":"56","author":"MTRA Terreri","year":"2016","unstructured":"Terreri MTRA, Bernardo WM, Len CA, et al. Guidelines for the management and treatment of periodic fever syndromes Familial mediterranean fever. Rev Bras Reumatol Engl Ed. 2016;56:37\u201343. https:\/\/doi.org\/10.1016\/j.rbre.2015.08.019.","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"4276_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.rbre.2015.08.020","volume":"56","author":"MTRA Terreri","year":"2016","unstructured":"Terreri MTRA, Bernardo WM, Len CA, et al. Guidelines for the management and treatment of periodic fever syndromes: Cryopyrin-associated periodic syndromes (cryopyrinopathies - CAPS). Rev Bras Reumatol Engl Ed. 2016;56:44\u201351. https:\/\/doi.org\/10.1016\/j.rbre.2015.08.020.","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"4276_CR14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1007\/s00112-022-01490-z","volume":"170","author":"T Hospach","year":"2022","unstructured":"Hospach T, Neudorf U, Lilienthal E, et al. [Updated recommendations for action according to the S2k guidelines on Kawasaki syndrome]. Monatsschr Kinderheilkd. 2022;170:1122\u20134. https:\/\/doi.org\/10.1007\/s00112-022-01490-z.","journal-title":"Monatsschr Kinderheilkd"},{"key":"4276_CR15","unstructured":"https:\/\/register.awmf.org\/assets\/guidelines\/185-002l_S2k_Immunglobulin_A_Vaskulitis_Purpura_Sch%C3%B6nlein-Henoch_2022-08.pdf. Accessed 22 July 2024."},{"key":"4276_CR16","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Protocole National de Diagnostic et de Soins: Maladie de Kawasaki. 2022. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2022-09\/pndskawasaki_version_finale_1.pdf. Accessed 22 July 2024."},{"key":"4276_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13052-021-00962-4","volume":"47","author":"A Marchesi","year":"2021","unstructured":"Marchesi A, Rigante D, Cimaz R, et al. Revised recommendations of the Italian society of pediatrics about the general management of Kawasaki disease. Ital J Pediatr. 2021;47:16. https:\/\/doi.org\/10.1186\/s13052-021-00962-4.","journal-title":"Ital J Pediatr"},{"key":"4276_CR18","unstructured":"https:\/\/www.santa.lt\/uploads\/vaskulitai.pdf. Accessed 22 July 2024."},{"key":"4276_CR19","unstructured":"https:\/\/www.aeped.es\/sites\/default\/files\/documentos\/19_kawasaki.pdf. Accessed 22 July 2024."},{"key":"4276_CR20","unstructured":"https:\/\/www.aeped.es\/sites\/default\/files\/documentos\/20_vasculitis_iga.pdf. Accessed 22 July 2024."},{"key":"4276_CR21","unstructured":"Recommendations. Fever in under 5s: assessment and initial management. Guidance: NICE. 2019. https:\/\/www.nice.org.uk\/guidance\/ng143\/chapter\/recommendations#kawasaki-disease. Accessed 22 July 2024."},{"key":"4276_CR22","unstructured":"https:\/\/med-expert.com.ua\/journals\/wp-content\/uploads\/2020\/12\/13-1.pdf. Accessed 22 July 2024."},{"key":"4276_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12969-020-0409-3","volume":"18","author":"S Hansmann","year":"2020","unstructured":"Hansmann S, Lainka E, Horneff G, et al. Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD\/HIDS: a German PRO-KIND initiative. Pediatr Rheumatol Online J. 2020;18:17. https:\/\/doi.org\/10.1186\/s12969-020-0409-3.","journal-title":"Pediatr Rheumatol Online J"},{"key":"4276_CR24","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.revmed.2023.10.441","volume":"44","author":"S Georgin-Lavialle","year":"2023","unstructured":"Georgin-Lavialle S, Savey L, Cuisset L, et al. French protocol for the diagnosis and management of Familial mediterranean fever. Rev Med Interne. 2023;44:602\u201316. https:\/\/doi.org\/10.1016\/j.revmed.2023.10.441.","journal-title":"Rev Med Interne"},{"key":"4276_CR25","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Protocole National de Diagnostic et de Soins (PNDS) Fi\u00e8vres r\u00e9currentes h\u00e9r\u00e9ditaires Syndromes p\u00e9riodiques associ\u00e9s \u00e0 la cryopyrine (CAPS). 2013. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2013-05\/pnds_-_syndromes_periodiques_associes_a_la_cryopyrine_caps_2013-05-15_15-23-40_118.pdf. Accessed 22 July 2024."},{"key":"4276_CR26","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Protocole National de Diagnostic et de Soins (PNDS) D\u00e9ficit en m\u00e9valonate kinase (MKD). 2015. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2015-07\/pnds_-_deficit_en_mevalonate_kinase_mkd.pdf. Accessed 22 July 2024."},{"key":"4276_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00393-018-0588-1","volume":"78","author":"T Kallinich","year":"2019","unstructured":"Kallinich T, Blank N, Braun T, et al. [Evidence-based treatment recommendations for Familial mediterranean fever: A joint statement by the society for pediatric and adolescent rheumatology and the German society for rheumatology]. Z Rheumatol. 2019;78:91\u2013101. https:\/\/doi.org\/10.1007\/s00393-018-0588-1.","journal-title":"Z Rheumatol"},{"key":"4276_CR28","unstructured":"https:\/\/www.aeped.es\/sites\/default\/files\/documentos\/30_enfermedades_autoinflamatorias.pdf. Accessed 22 July 2024."},{"key":"4276_CR29","unstructured":"Canakinumab for treating periodic fever syndromes (TRAPS, HIDS\/MKD and FMF) ages 2 years and older. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2020\/03\/Canakinumab-for-treating-periodic-fever-syndromes-TRAPS-HIDSMKD-and-FMF-ages-2-years-and-older.pdf. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2019-08\/pnds_pfapa_vf_050819_2.pdf."},{"key":"4276_CR30","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Protocole National de Diagnostic et de soins (PNDS): PFAPA: Fi\u00e8vre p\u00e9riodique \u2013stomatite \u2013 pharyngite \u2013 ad\u00e9nopathie. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2019-08\/pnds_pfapa_vf_050819_2.pdf. Accessed 22 July 2024."},{"key":"4276_CR31","unstructured":"https:\/\/www.aeped.es\/sites\/default\/files\/documentos\/34_pfapa.pdf. Accessed 22 July 2024."},{"key":"4276_CR32","unstructured":"Starship guidelines: Kawasaki disease. 2022. https:\/\/starship.org.nz\/guidelines\/kawasaki-disease\/. Accessed22 July 2024."},{"key":"4276_CR33","unstructured":"Starship guidelines: Henoch-Schonlein purpura. https:\/\/starship.org.nz\/guidelines\/henoch-schonlein-purpura\/. Accessed22 July 2024."},{"key":"4276_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s42269-023-01059-0","volume":"47","author":"A Abdel Baky","year":"2023","unstructured":"Abdel Baky A, Omar TEI, Amer YS, et al. Adapting global evidence-based practice guidelines to the Egyptian healthcare context: the Egyptian pediatric clinical practice guidelines committee (EPG) initiative. Bull Natl Res Cent. 2023;47:88. https:\/\/doi.org\/10.1186\/s42269-023-01059-0.","journal-title":"Bull Natl Res Cent"},{"key":"4276_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/acr.22666","volume":"68","author":"R Mina","year":"2016","unstructured":"Mina R, Harris JG, Klein-Gitelman MS, et al. Initial benchmarking of the quality of medical care in Childhood-Onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2016;68:179\u201386. https:\/\/doi.org\/10.1002\/acr.22666.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04276-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04276-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04276-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:29:54Z","timestamp":1775723394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04276-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4276"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04276-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}